Analyst Consensus
- Current Price
- 173.63 $
- Target (Low)
- 170.00 $
- Target (Mean)
- 216.04 $
- Target (High)
- 236.00 $
- Recommendation
- Buy
- Number of Analysts
- 23
Recommendation Distribution
Recommendation Distribution| Strong Buy | 5 |
|---|
| Buy | 13 |
|---|
| Hold | 6 |
|---|
| Sell | 1 |
|---|
| Strong Sell | 0 |
|---|
Key Ratios
- Net Profit Margin
- 5.9%
- Operating Margin
- 7.3%
- Gross Margin
- 42.4%
- Return on Equity (ROE)
- 6.6%
- Return on Assets (ROA)
- 3.5%
- Revenue Growth
- 2.3%
- Earnings Growth
- -44.5%
- Debt/Equity
- 23.99
- Current Ratio
- 1.09
- Beta
- 0.47
Recent Rating Changes
Recent Rating Changes| Date | Firm | Change |
|---|
| May 27, 2026 | Mizuho | Outperform → Outperform |
| May 26, 2026 | Barclays | Equal-Weight → Equal-Weight |
| May 22, 2026 | Morgan Stanley | Overweight → Overweight |
| May 11, 2026 | Bernstein | Market Perform → Market Perform |
| May 5, 2026 | RBC Capital | Outperform → Outperform |
| May 4, 2026 | UBS | Buy → Buy |